Axa’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-66,866
Closed -$6.18M 1075
2024
Q4
$6.18M Buy
66,866
+38,117
+133% +$3.74M 0.02% 485
2024
Q3
$2.78M Buy
28,749
+6,182
+27% +$556K 0.01% 682
2024
Q2
$1.94M Buy
22,567
+1,945
+9% +$163K 0.01% 766
2024
Q1
$1.7M Hold
20,622
0.01% 783
2023
Q4
$1.38M Buy
+20,622
New +$1.34M ﹤0.01% 792
2022
Q2
Sell
-7,291
Closed -$412K 1136
2022
Q1
$412K Hold
7,291
﹤0.01% 1067
2021
Q4
$379K Sell
7,291
-29,916
-80% -$1.54M ﹤0.01% 1058
2021
Q3
$2.22M Buy
+37,207
New +$2.34M 0.01% 838
2017
Q1
Sell
-15,210
Closed -$499K 1280
2016
Q4
$499K Buy
+15,210
New +$493K ﹤0.01% 1053

Other funds holding EHC

Axa's EHC Position: Q1 2025 in Review

Axa sold out of Encompass Health (EHC) in Q1 2025, closing a stake of 66,866 shares — an estimated $6.18M sold.

Axa first reported a position in EHC in Q4 2016 and held it in 9 quarters. The position peaked at $6.18M in Q4 2024. 537 funds tracked by Wall St. Rank hold EHC as of Q1 2025.

  • Axa reported no remaining Encompass Health position as of Q1 2025 after selling out during the quarter.
  • Axa sold 66,866 Encompass Health shares in Q1 2025, an estimated $6.18M.
  • Axa first reported a position in Encompass Health in Q4 2016 and held it in 9 quarters.
  • Axa's Encompass Health position peaked at $6.18M in Q4 2024.
  • 537 funds tracked by Wall St. Rank held Encompass Health as of Q1 2025.

Based on Axa's 13F filing for Q1 2025, filed 15 May 2025.